MLTX vs. QQQ
MLTX (MoonLake Immunotherapeutics) is a stock, while QQQ (Invesco QQQ ETF) is Nasdaq-100 fund tracking the NASDAQ-100 Index. Over the past 5 years, MLTX returned 14.86%/yr vs 15.10%/yr for QQQ. At a 0.17 correlation, their price movements are largely independent.
Performance
MLTX vs. QQQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MLTX achieves a 54.86% return, which is significantly higher than QQQ's 16.13% return.
MLTX
- 1D
- 0.25%
- 1M
- 9.20%
- 6M
- 12.82%
- YTD
- 54.86%
- 1Y
- -58.35%
- 3Y*
- -27.82%
- 5Y*
- 14.86%
- 10Y*
- —
QQQ
- 1D
- -1.90%
- 1M
- -1.22%
- 6M
- 13.75%
- YTD
- 16.13%
- 1Y
- 29.05%
- 3Y*
- 24.08%
- 5Y*
- 15.10%
- 10Y*
- 21.19%
MLTX vs. QQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MLTX MoonLake Immunotherapeutics | 54.86% | -75.66% | -10.33% | 475.14% | 6.17% | -13.02% | 11.91% |
QQQ Invesco QQQ ETF | 16.13% | 20.77% | 25.58% | 54.86% | -32.58% | 27.42% | 10.75% |
Correlation
The correlation between MLTX and QQQ is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2020 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLTX vs. QQQ — Risk / Return Rank
MLTX
QQQ
MLTX vs. QQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MLTX | QQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.07 | ||
| Sortino ratioReturn per unit of downside risk | -1.32 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.28 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.65 | 2.44 | -3.09 |
| Martin ratioReturn relative to average drawdown | -0.88 | 8.74 | -9.62 |
Loading charts...
Drawdowns
MLTX vs. QQQ - Drawdown Comparison
The maximum MLTX drawdown since its inception was -90.22%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for MLTX and QQQ.
Loading charts...
Drawdown Indicators
| MLTX | QQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.22% | -82.97% | -7.25% |
Max Drawdown (1Y)Largest decline over 1 year | -89.93% | -11.96% | -77.97% |
Max Drawdown (3Y)Largest decline over 3 years | -90.22% | -22.77% | -67.45% |
Max Drawdown (5Y)Largest decline over 5 years | -90.22% | -35.12% | -55.10% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.12% | — |
Current DrawdownCurrent decline from peak | -68.04% | -4.51% | -63.53% |
Average DrawdownAverage peak-to-trough decline | -29.87% | -32.67% | +2.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 66.52% | 3.33% | +63.19% |
Volatility
MLTX vs. QQQ - Volatility Comparison
MoonLake Immunotherapeutics (MLTX) has a higher volatility of 18.34% compared to Invesco QQQ ETF (QQQ) at 8.69%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MLTX | QQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.34% | 8.69% | +9.65% |
Volatility (6M)Calculated over the trailing 6-month period | 49.16% | 15.40% | +33.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 117.01% | 18.61% | +98.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.57% | 22.80% | +68.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.11% | 22.44% | +63.67% |
Dividends
MLTX vs. QQQ - Dividend Comparison
MLTX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.43%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MLTX MoonLake Immunotherapeutics | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ ETF | 0.43% | 0.45% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% |
Frequently Asked Questions
MLTX and QQQ have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MLTX has higher volatility (18.34%) compared to QQQ (8.69%). In terms of maximum drawdown, MLTX dropped -90.22% vs QQQ's -82.97%.
QQQ currently has the higher Sharpe Ratio (1.57 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MLTX and QQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer